{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:33:24Z","timestamp":1788946404842,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jiac.2020.06.019","type":"journal-article","created":{"date-parts":[[2020,7,19]],"date-time":"2020-07-19T07:05:42Z","timestamp":1595142342000},"page":"1205-1212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Comparison of QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold In-Tube, and T-SPOT.TB among patients with tuberculosis"],"prefix":"10.1016","volume":"26","author":[{"given":"Keita","family":"Takeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Suzukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Narumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuharu","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhisa","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Tohma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2020.06.019_bib1","series-title":"Global tuberculosis report 2019. Global tuberculosis report","year":"2019"},{"key":"10.1016\/j.jiac.2020.06.019_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The Global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.jiac.2020.06.019_bib3","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1183\/09031936.00214014","article-title":"Towards tuberculosis elimination: an action framework for low-incidence countries","volume":"45","author":"L\u00f6nnroth","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2020.06.019_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3899\/jrheum.140099","article-title":"Performance of the tuberculin skin test and interferon-\u03b3 release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches","volume":"91","author":"Goletti","year":"2014","journal-title":"J\u00a0Rheumatol Suppl"},{"issue":"Suppl 3","key":"10.1016\/j.jiac.2020.06.019_bib5","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1086\/651492","article-title":"HIV infection-associated tuberculosis: the epidemiology and the response","volume":"50","author":"Getahun","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2020.06.019_bib6","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries","volume":"46","author":"Getahun","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2020.06.019_bib7","doi-asserted-by":"crossref","first-page":"6568","DOI":"10.4081\/idr.2016.6568","article-title":"Tuberculosis biomarkers: from diagnosis to protection","volume":"8","author":"Goletti","year":"2016","journal-title":"Infect Dis Rep"},{"key":"10.1016\/j.jiac.2020.06.019_bib8","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1183\/13993003.01012-2016","article-title":"Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis","volume":"48","author":"Petruccioli","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2020.06.019_bib9","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1183\/13993003.02033-2015","article-title":"First independent evaluation of QuantiFERON-TB Plus performance","volume":"47","author":"Barcellini","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2020.06.019_bib10","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1183\/13993003.00510-2016","article-title":"First evaluation of QuantiFERON-TB Gold Plus performance in contact screening","volume":"48","author":"Barcellini","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2020.06.019_bib11","first-page":"588","article-title":"First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB plus","volume":"73","author":"Petruccioli","year":"2016","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jiac.2020.06.019_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tube.2017.06.002","article-title":"Analytical evaluation of QuantiFERON- plus and QuantiFERON- gold in-tube assays in subjects with or without tuberculosis","volume":"106","author":"Petruccioli","year":"2017","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.jiac.2020.06.019_bib13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.cmi.2016.05.006","article-title":"Equal sensitivity of the new generation QuantiFERON-TB Gold plus in direct comparison with the previous test version QuantiFERON-TB Gold IT","volume":"22","author":"Hoffmann","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2020.06.019_bib14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.5588\/ijtld.17.0721","article-title":"Multicenter study of QuantiFERON\u00ae-TB Gold Plus in patients with active tuberculosis","volume":"22","author":"Horne","year":"2018","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.jiac.2020.06.019_bib15","doi-asserted-by":"crossref","first-page":"30617","DOI":"10.1038\/srep30617","article-title":"Evaluation of QuantiFERON-TB gold plus for detection of Mycobacterium tuberculosis infection in Japan","volume":"6","author":"Yi","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiac.2020.06.019_bib16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jiac.2017.10.009","article-title":"Sensitivity and specificity of QuantiFERON-TB gold plus compared with QuantiFEROTB gold in-tube and T-SPOT.TB on active tuberculosis in Japan","volume":"24","author":"Takasaki","year":"2018","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2020.06.019_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tube.2017.11.014","article-title":"A\u00a0multicentre verification study of the QuantiFERON\u00ae-TB Gold Plus assay","volume":"108","author":"Pieterman","year":"2018","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jiac.2020.06.019_bib18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00408-010-9238-3","article-title":"Comparison of T-cell interferon-gamma release assays for Mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis","volume":"188","author":"Kobashi","year":"2010","journal-title":"Lung"},{"key":"10.1016\/j.jiac.2020.06.019_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01360-17","article-title":"Quantitative analysis of gamma interferon release assay response in children with latent and active tuberculosis","volume":"56","author":"Lombardi","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2020.06.019_bib21","author":"T-SPOT"},{"key":"10.1016\/j.jiac.2020.06.019_bib22","first-page":"299","article-title":"CD8 response measured by QuantiFERON-TB Gold Plus and tuberculosis disease status","volume":"78","author":"Lee","year":"2019","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jiac.2020.06.019_bib23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely-available easy-to-use software \u201cEZR\u201d (Easy R) for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2020.06.019_bib24","first-page":"517","article-title":"Comparison study of sensitivity of QuantiFERON\u00ae TB Gold Plus with existing IGRAs in the patients with active pulmonary tuberculosis","volume":"93","author":"Fukushima","year":"2018","journal-title":"Kekkaku"},{"key":"10.1016\/j.jiac.2020.06.019_bib25","first-page":"87","article-title":"Clinical features associated with false-negative T-SPOT. TB assay results in patients with pulmonary tuberculosis","volume":"93","author":"Hosoda","year":"2018","journal-title":"Kekkaku"},{"key":"10.1016\/j.jiac.2020.06.019_bib26","doi-asserted-by":"crossref","first-page":"690","DOI":"10.5588\/ijtld.16.0764","article-title":"The sensitivity of the QuantiFERON\u00ae-TB Gold Plus assay in Zambian adults with active tuberculosis","volume":"21","author":"Telisinghe","year":"2017","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.jiac.2020.06.019_bib27","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies","volume":"7","author":"Barry","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jiac.2020.06.019_bib28","first-page":"1021","article-title":"Waning of the specific interferon-gamma response after years of tuberculosis infection","volume":"11","author":"Mori","year":"2007","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.jiac.2020.06.019_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tube.2018.03.002","article-title":"Seasonal variation in the performance of QuantiFERON-TB Gold In-Tube assays used for the diagnosis of tuberculosis infection","volume":"110","author":"Tebruegge","year":"2018","journal-title":"Tuberculosis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20302105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20302105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:00:48Z","timestamp":1761159648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X20302105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1341321X20302105"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2020.06.019","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold In-Tube, and T-SPOT.TB among patients with tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2020.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}